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Infectious Disease Epidemiology Report 
Tuberculosis, 2012 
 





Tuberculosis (TB) is caused by the bacteria 
Mycobacterium tuberculosis.  The bacteria are 
spread through the air by droplets when a person 
with infectious TB coughs, talks, sings or sneezes. 
Tuberculosis is only infectious when the disease is 
in the lungs (pulmonary) or larynx. Extrapulmonary 
disease is not infectious and occurs outside of the 
lungs or larynx. Latent tuberculosis infections 
(LTBI) occur when the body’s immune system 
keeps the bacteria under control and inactive, so 
that disease does not develop. Individuals with 
LTBI are not symptomatic and not infectious to 
others. 
 
Two tests are available to screen for tuberculosis, 
either can be used. The TB skin test, called the 
tuberculin skin test (TST), has been used for many 
years. A newer blood test called interferon gamma 
release assays (IGRAs) is also available. Both tests 
do not differentiate between latent or active TB. All 
positive results require additional evaluation. 
 
Maine monitors the incidence of active TB through 
mandatory reporting by health care providers, 
clinical laboratories and other public health 
partners. Although not reportable, Maine also 
monitors LTBI diagnoses.  
Methods 
All active TB cases in Maine are evaluated by a 
healthcare provider in consultation with a TB 
Consultant physician; and receive case 
management services and directly observed 
therapy (DOT) by a Public Health Nurse (PHN). 
The TB Control Program coordinates TB clinic visits 
and routinely reviews case management with PHN 
and the State Epidemiologist. Cases are also 
reviewed with TB Consultants at quarterly 
meetings. 
 
A confirmed case of TB must meet either clinical 
criteria or be laboratory confirmed with one of the 
following tests: isolation of M. tuberculosis; 
demonstration of M. tuberculosis by polymerase 
chain reaction (PCR); or demonstration of acid-fast  




A total of 17 confirmed cases of TB were reported 
in 2012 (Figure 1), almost double the number of 
cases from 2011.  No cases of multi–drug resistant 
(MDR) TB or extensively drug resistant (XDR) TB 




The incidence rate of TB in Maine in 2012, 1.3 
cases per 100,000 population, is less than the 
national rate of 3.2 (Figure 2).  Nationwide, the 




The median age of TB cases was 47 years (range 
3 years - 88 years). Cases resided in five counties, 
Androscoggin (3), Aroostook (1), Cumberland (10), 
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Table 1. Clinical characteristics of TB Cases, 
Maine, 2012 
 Cases (%) 
Pulmonary 13 (76) 
Extrapulmonary 4 (24) 
  
Tuberculin skin test (TST) 15 (88) 
--Positive TST 5  
IGRA 6 (35) 
--Positive IGRA 4  
  
Pulmonary cases (N = 13)  
Abnormal chest x-ray or CT scan 13 (100) 
Positive sputum culture 5 (38) 
Positive sputum acid fast bacilli 
(AFB) smear 
4 (31) 
Positive bronchial fluid culture 4 (31) 
 
Risk factor information was available for all cases. 
Three (18%) cases were co-infected with HIV. Ten 
(59%) cases were born outside of the US. Five 
(50%) arrived in the US less than a year before 
their diagnosis.  
 
Table 2. Characteristics and Risk Factors for TB 
Cases, Maine, 2012 
 Cases (%) 
Demographics  
Male 9 (53) 
Female 8 (47) 
  
Hispanic 1 (6) 
Non-Hispanic 16 (94) 
  
Asian 2 (12) 
Black or African American 7 (41) 
White 7 (41) 
Pacific Islander/Hawaiian 1 (6) 
  
Country of origin  
U.S. 7 (41) 
Non –U.S. 10 (59) 
Unknown 0 (0) 
  
Risk Factors  
Correctional facility at  time of 
diagnosis 
0 (0) 
Injected drug use in past year 0 (0) 
Non-injected drug use in past year 2 (12) 
Excess alcohol use within past 
year 
2 (12) 
Homeless within past year 1 (6) 
HIV status known 17 (100) 
Incomplete LTBI therapy 1 (6) 
 
There were nine contact investigations in 2012 (one 
patient investigation performed by another 
jurisdiction, two cases were considered not to be 
infectious and two cases were from the same family 
and had the same contacts). Eighty-seven percent 
(87%) of identified contacts were evaluated. Four 
individuals were identified with latent TB infection, 
and two (50%) started treatment. 
 
In 2012, Maine received 398 reports of persons 
with LTBI.  Eighty-four percent of LTBI cases were 
diagnosed among persons who are foreign- born. 
The country of birth reported includes 47 different 
countries (excluding the US) and 20 primary 
languages besides English were reported.  
Discussion 
Nationwide, the incidence of TB has decreased 
during recent years.  In Portland, collaboration 
between the Tuberculosis Control Program, Public 
Health Nursing and homeless shelters provides TB 
screening. There have been two outbreaks of TB in 
Maine among the homeless population in the past 
10 years. The Public Health Nursing program 
continues to screen all newly arriving primary 
refugees for TB to facilitate case finding and 
treatment initiation and completion. 
 
Early identification, reporting, prevention and 
targeted education about TB is necessary to keep 
TB disease from spreading and protect the public’s 
health. The evaluation and treatment of TB disease 
is more costly than LTBI treatment.  
  
All suspected or confirmed cases of active TB must 
be reported immediately to the Tuberculosis 
Control Program at Maine CDC by calling 1-800-
821-5821. Reporting of LTBI cases is encouraged. 
The state Health and Environmental Testing 
Laboratory (HETL) provides all confirmatory TB 
testing for the state.  
 
Additional information about tuberculosis is 
available at: 
• Maine CDC: www.maine.gov/idepi  
• Federal CDC: http://www.cdc.gov/tb/ 
• World Health Organization: 
http://www.who.int/tb/en/ 
